Nanoenabled Disruption of Multiple Barriers in Antigen Cross-Presentation of Dendritic Cells <i>via</i> Calcium Interference for Enhanced Chemo-Immunotherapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32427462.
- Also identified by DOI 10.1021/acsnano.0c03881.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chemo-immunotherapy holds the advantage of specific antitumor effects by activating T cell immune response. However, the efficiency of chemo-immunotherapy is restricted to the insufficient antigen presentation of dendritic cells (DCs) in the tumor immunosuppression microenvironment. Here, we rationally designed a simple yet versatile calcium ion nanogenerator to disrupt the autophagy inhibition condition within DCs, enrich damage-associated molecular patterns (DAMPs), and attenuate acidity in the tumor microenvironment. After chemotherapy, honeycomb calcium carbonate (CaCO<sub>3</sub>) nanoparticles (OVA@CaCO<sub>3</sub>, denoted as HOCN, ovalbumin (OVA) acted as skeleton) could preferentially accumulate in the tumor and display a series of benefits for disrupting multiple barriers in antigen cross-presentation of DCs: (i) recovering cell viability of DCs by HOCN-induced tumor acidity attenuating; (ii) disrupting the autophagy inhibition condition in DCs by generating Ca<sup>2+</sup> in cells; (iii) improving maturation of DCs by Ca<sup>2+</sup> overloading-mediated enhanced DAMP release from tumor cells. In addition, HOCN can also disrupt the immunosuppressive microenvironment by reducing the infiltration of immunosuppressive cells and factors. We believe regulation of the intratumoral Ca<sup>2+</sup> offers an alternative strategy for improving cancer chemo-immunotherapy.
Medical subject headings
- Antigen Presentation
- Cross-Priming